1.Burns, A. Clinical diagnosis of Alzheimer's disease. Dementia 1991, 2; 186–194.
2.Goodall, HB, McHarg, JF, Anderson, JM, Robertson, J. Acanthocytosis in disparate clinical states-myelodysplasia and Alzheimer's disease. Leukemia Research 1991; 15 (Supplement): 19.
3.Goodall, HBet al.Irregular distortion of the erythrocytes (Acanthocytes, Spur Cells) in senile dementia. Disease Markers 1994; 12: 23–41.
4.Eastham, RD, Jancar, J. Macrocytosis in Down's syndrome and during long-term anticonvulsant therapy. J Clin Pathology 1970; 23: 296–298.
5.Eastham, RD, Jancar, J. Macrocytosis and Down's syndrome. Br J Psychiatry 1983; 143: 203–204.
6.Hewitt, KE, Carter, G, Jancer, J. Ageing in Down's syndrome. Br J Psychiatry 1985; 147: 58–62.
7.Terman, LM, Merrill, MA. Measuring Intelligence. Boston: Houghton Mifflin, 1937
8.Lansdall-Welfare, RW, Hewitt, KE. Macrocytosis and cognitive decline in Down's syndrome. Br J Psychiatry 1986; 148: 482–3.
9.Akin, K. Macrocytosis and leukopenia in Down's syndrome. J Am Med Association 1988; 259: 842.
10.Wachtel, TJ, Peuschel, SM. Macrocytosis in Down syndrome. Am J Mental Retardation 1991; 95: 417–20.
11.Prasher, VP. Increase in mean cell volume – a possible peripheral marker for Alzheimer's disease? J Int Geriatric Psychiatry 1997; 12: 130–1.
12.Prasher, VP. Down syndrome, dementia and macrocytosis. Br J Developmental Disabilities 1994; 90: 131–134.
13.World Health Organisation. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva: WHO, 1993
14.Prasher, VP. Screening of physical morbidity in adults with Down syndrome. Down's Syndrome Research and Practice 1994; 2: 59–66.
15.World Health Organisation. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO, 1992
16.World Health Organisation. ICD-10 Symptom Checklist for Mental Disorders. Version 1.1. Geneva: WHO, 1994
17.Roth, Met al.CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986; 149: 698–709.
18.Aylward, EHet al.Diagnosis of dementia in individuals with intellectual disability. J Intellectual Disability Res 1997; 41, 152–164.
19.Tycko, DH. Flow-cytometric light scattering measurement of red blood cell volume and haemoglobin concentration. Applied Optics 1985; 24: 1355–1365.
20.Dickinson, MJ, Singh, I. Down's syndrome, dementia, and superoxide dismutase. Br J Psychiatry 1993; 162: 811–7.
21.Bosman, GJet al.Erythrocyte membrane changes of individuals with Down's syndrome in various stages of Alzheimer-type dementia. Neurobiology of Aging 1993, 14; 223–8.
22.Lee, GRet al.Clinical Haematology. Philadelphia: Lea and Febiger, 1993
23.Nakamura, E, Tanaka, S. Biological ages of adult men and women with Down's syndrome and its changes with aging. Mechanisms of Ageing and Development 1998; 105: 89–103.
24.Okamoto, Net al.Premature aging syndrome with osteosarcoma, cataracts, diabetes mellitus, osteoporosis, erythroid macrocytosis, severe growth and developmental deficiency. Am J Medical Genetics 1997; 69: 169–170.
25.Hanin, Iet al.Elevated red blood cell/plasma choline ratio in dementia of the Alzheimer type: clinical and polysomnography correlates. Psychiatry Research 1984; 13: 167–173.
26.Greenwald, BSet al.Alzheimer's disease, dexamethasone suppression, dementia severity, and affective symptoms. Am J Psychiatry 1986; 143: 442–446.
27.Sinet, PM. Metabolism of oxygen derivatives in Down's Syndrome. Annals of the New York Academy of Sciences 1982; 396: 83–94.
28.Marcus, DLet al.Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurology 1998; 150: 40–4.
29.Subbarao, KV, Richardson, JS, Ang, L. Autopsy samples of Alzheimer's cortex show increase peroxidation in vitro. J Neurochemistry 1990; 55: 342–345.
30.Blass, JPet al.Red blood cell abnormalities in Alzheimer disease. J Am Geriatric Society 1985; 33: 401–5.